niacinamide has been researched along with Diabetic Glomerulosclerosis in 16 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Excerpt | Relevance | Reference |
---|---|---|
"The attenuation of diabetic kidney disease (DKD) by metabolic surgery is enhanced by pharmacotherapy promoting renal fatty acid oxidation (FAO)." | 1.72 | Dietary restriction and medical therapy drives PPARα-regulated improvements in early diabetic kidney disease in male rats. ( Abdelaal, M; Abrahamsson, S; Brennan, EP; Chuah, YHD; Docherty, NG; Eckhardt, H; Elliott, JA; Fändriks, L; Fearon, N; Godson, C; Hutter, M; le Roux, CW; Malmodin, D; Martin, WP; Nair, M; Pedersen, A, 2022) |
"augusta leaves (AA) against type 2 diabetes mellitus (T2DM) and its associated nephropathy and cardiomyopathy in experimental rats." | 1.42 | Abroma augusta L. (Malvaceae) leaf extract attenuates diabetes induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response. ( De Feo, V; Dewanjee, S; Gangopadhyay, M; K Dua, T; Khanra, R; Sahu, R; Zia-Ul-Haq, M, 2015) |
"Eighteen rats with diabetic nephropathy and 6 rats without induced nephropathy were divided into 4 groups, each containing 6 animals." | 1.39 | Effect of silymarin on streptozotocin-nicotinamide-induced type 2 diabetic nephropathy in rats. ( Jose, MA; Kumar, BN; Sathyamurthy, D; Sheela, N, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.25) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (6.25) | 29.6817 |
2010's | 7 (43.75) | 24.3611 |
2020's | 7 (43.75) | 2.80 |
Authors | Studies |
---|---|
Yan, LJ | 1 |
Martin, WP | 1 |
Nair, M | 1 |
Chuah, YHD | 1 |
Malmodin, D | 1 |
Pedersen, A | 1 |
Abrahamsson, S | 1 |
Hutter, M | 1 |
Abdelaal, M | 1 |
Elliott, JA | 1 |
Fearon, N | 1 |
Eckhardt, H | 1 |
Godson, C | 1 |
Brennan, EP | 1 |
Fändriks, L | 1 |
le Roux, CW | 1 |
Docherty, NG | 1 |
Noei Razliqi, R | 1 |
Ahangarpour, A | 1 |
Mard, SA | 1 |
Khorsandi, L | 1 |
Kpemissi, M | 1 |
Potârniche, AV | 1 |
Lawson-Evi, P | 1 |
Metowogo, K | 1 |
Melila, M | 1 |
Dramane, P | 1 |
Taulescu, M | 1 |
Chandramohan, V | 1 |
Suhas, DS | 1 |
Puneeth, TA | 1 |
S, VK | 1 |
Vlase, L | 1 |
Andrei, S | 1 |
Eklu-Gadegbeku, K | 1 |
Sevastre, B | 1 |
Veerapur, VP | 1 |
Uddandrao, VVS | 1 |
Parim, B | 1 |
Ramavat, R | 1 |
Pothani, S | 1 |
Vadivukkarasi, S | 2 |
P, P | 1 |
P, C | 1 |
Ganapathy, S | 1 |
Mujeeb, M | 1 |
Ahad, A | 1 |
Aqil, M | 1 |
Siddiqui, WA | 1 |
Najmi, AK | 1 |
Akhtar, M | 1 |
Shrivastava, A | 1 |
Qadir, A | 1 |
Moolakkadath, T | 1 |
Wright, MB | 1 |
Varona Santos, J | 1 |
Kemmer, C | 1 |
Maugeais, C | 1 |
Carralot, JP | 1 |
Roever, S | 1 |
Molina, J | 1 |
Ducasa, GM | 1 |
Mitrofanova, A | 1 |
Sloan, A | 1 |
Ahmad, A | 1 |
Pedigo, C | 1 |
Ge, M | 1 |
Pressly, J | 1 |
Barisoni, L | 1 |
Mendez, A | 1 |
Sgrignani, J | 1 |
Cavalli, A | 1 |
Merscher, S | 1 |
Prunotto, M | 1 |
Fornoni, A | 1 |
Hsu, JD | 1 |
Wu, CC | 1 |
Hung, CN | 1 |
Wang, CJ | 1 |
Huang, HP | 1 |
Kishore, L | 1 |
Kaur, N | 1 |
Singh, R | 1 |
Sathibabu Uddandrao, VV | 1 |
Brahmanaidu, P | 1 |
Ravindarnaik, R | 1 |
Suresh, P | 1 |
Saravanan, G | 1 |
Sheela, N | 1 |
Jose, MA | 1 |
Sathyamurthy, D | 1 |
Kumar, BN | 1 |
Khanra, R | 1 |
Dewanjee, S | 1 |
K Dua, T | 1 |
Sahu, R | 1 |
Gangopadhyay, M | 1 |
De Feo, V | 1 |
Zia-Ul-Haq, M | 1 |
Ziamajidi, N | 1 |
Nasiri, A | 1 |
Abbasalipourkabir, R | 1 |
Sadeghi Moheb, S | 1 |
Yang, WS | 1 |
Chang, JW | 1 |
Han, NJ | 1 |
Lee, SK | 1 |
Park, SK | 1 |
Thomas, MC | 1 |
Tikellis, C | 1 |
Burns, WC | 1 |
Thallas, V | 1 |
Forbes, JM | 1 |
Cao, Z | 1 |
Osicka, TM | 1 |
Russo, LM | 1 |
Jerums, G | 1 |
Ghabrial, H | 1 |
Cooper, ME | 1 |
Kantharidis, P | 1 |
Wahlberg, G | 1 |
Carlson, LA | 1 |
Wasserman, J | 1 |
Ljungqvist, A | 1 |
1 review available for niacinamide and Diabetic Glomerulosclerosis
Article | Year |
---|---|
The Nicotinamide/Streptozotocin Rodent Model of Type 2 Diabetes: Renal Pathophysiology and Redox Imbalance Features.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucose | 2022 |
15 other studies available for niacinamide and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Dietary restriction and medical therapy drives PPARα-regulated improvements in early diabetic kidney disease in male rats.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Fenofibrate; Kidney; Male; Niacinamide; PPAR alp | 2022 |
Gentisic acid protects against diabetic nephropathy in Nicotinamide-Streptozotocin administered male mice by attenuating oxidative stress and inflammation: The role of miR-200a/Keap1/Nrf2 pathway, renin-angiotensin system (RAS) and NF-кB.
Topics: Angiotensins; Animals; Anti-Inflammatory Agents; Antioxidants; Diabetes Mellitus, Experimental; Diab | 2023 |
Nephroprotective effect of Combretum micranthum G. Don in nicotinamide-streptozotocin induced diabetic nephropathy in rats: In-vivo and in-silico experiments.
Topics: Animals; Biomarkers; Blood Glucose; Catechin; Combretum; Diabetes Mellitus, Experimental; Diabetic N | 2020 |
Effect of S-allylcysteine against diabetic nephropathy via inhibition of MEK1/2-ERK1/2-RSK2 signalling pathway in streptozotocin-nicotinamide-induced diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; MAP Kinase Signaling Syste | 2023 |
Ameliorative effect of rubiadin-loaded nanocarriers in STZ-NA-induced diabetic nephropathy in rats: formulation optimization, molecular docking, and in vivo biological evaluation.
Topics: Animals; Anthraquinones; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Liposomes; Molecul | 2022 |
Compounds targeting OSBPL7 increase ABCA1-dependent cholesterol efflux preserving kidney function in two models of kidney disease.
Topics: Animals; ATP Binding Cassette Transporter 1; Biological Transport; Cells, Cultured; Cholesterol; Dia | 2021 |
Myrciaria cauliflora extract improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-nicotinamide mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Inflammation; Mice; Myrtaceae; Nia | 2016 |
Nephroprotective effect of Paeonia emodi via inhibition of advanced glycation end products and oxidative stress in streptozotocin-nicotinamide induced diabetic nephropathy.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glycation End Products, Advanced; | 2017 |
Restorative potentiality of S-allylcysteine against diabetic nephropathy through attenuation of oxidative stress and inflammation in streptozotocin-nicotinamide-induced diabetic rats.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cysteine; Diabetes Mellitus, Experimental; Diabetic Ne | 2019 |
Effect of silymarin on streptozotocin-nicotinamide-induced type 2 diabetic nephropathy in rats.
Topics: Albuminuria; Animals; Blood Glucose; Case-Control Studies; Creatinine; Diabetes Mellitus, Experiment | 2013 |
Abroma augusta L. (Malvaceae) leaf extract attenuates diabetes induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response.
Topics: Adenosine Triphosphate; Animals; Biomarkers; Blood Glucose; Body Weight; Cardiomyopathies; Diabetes | 2015 |
Effects of garlic extract on TNF-α expression and oxidative stress status in the kidneys of rats with STZ + nicotinamide-induced diabetes.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Blood Glucose; Diabetes Mellitus, Exper | 2017 |
Spleen tyrosine kinase mediates high glucose-induced transforming growth factor-β1 up-regulation in proximal tubular epithelial cells.
Topics: Base Sequence; Butadienes; Cell Line; Diabetic Nephropathies; DNA Primers; Epithelial Cells; Glucose | 2012 |
Reduced tubular cation transport in diabetes: prevented by ACE inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Transport; Cations; Diabetes Mellitus, | 2003 |
Protective effect of nicotinamide against nephropathy in diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fluorescent Antibody Technique; Hi | 1985 |